ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617965; 2) Community: the network communities that were significantly associated with the response to NSC 617965; 3) Molecule: the relationships between components within communities and NSC 617965; 4) MDR: the compounds that were significantly associated with the NSC 617965.

NSC Compound Enrichment Correlation
NSC 755469 Null 0.0382675857669585 0.2296899
NSC 756134 GSK1023156A 0.0382675857669585 0.21460115
NSC 756170 GSK317315A 0.0382675857669585 0.18879581
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.0382675857669585 -0.24778922
NSC 92915 ANTINEOPLASTIC-92915 0.0382675857669585 -0.052782449
NSC 100290 Doxypyrromycin hydrochloride 0.0382675857669588 0.58685882
NSC 114382 Null 0.0382675857669588 0.34446179
NSC 116693 Null 0.0382675857669588 -0.028157882
NSC 116878 Cardiac glycoside 0.0382675857669588 0.40822651
NSC 125845 Null 0.0382675857669588 0.3703174
Total:114  Current:90    [First] [Prev] [Next] [Last]